Increased Risk of Bleeding in Patients on Clopidogrel Therapy After Drug-Eluting Stents Implantation | Zendy

Thomas T. Tsai | Zendy; P. Michael Ho | Zendy; Stanley Xu | Zendy; J. David Powers | Zendy; Nikki M. Carroll | Zendy; Susan Shetterly | Zendy; Thomas M. Maddox | Zendy; John S. Rumsfeld | Zendy; Karen L. Margolis | Zendy; Alan S. Go | Zendy; David J. Magid | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Increased Risk of Bleeding in Patients on Clopidogrel Therapy After Drug-Eluting Stents Implantation

Author(s) -

Thomas T. Tsai,

P. Michael Ho,

Stanley Xu,

J. David Powers,

Nikki M. Carroll,

Susan Shetterly,

Thomas M. Maddox,

John S. Rumsfeld,

Karen L. Margolis,

Alan S. Go,

David J. Magid

Publication year - 2010

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.109.919001

Subject(s) - clopidogrel , medicine , drug eluting stent , myocardial infarction , relative risk , cardiology , lower risk , surgery , confidence interval , percutaneous coronary intervention

Studies suggest that extended clopidogrel use after drug-eluting stent (DES) implantation may decrease the risk of myocardial infarction (MI) and death. Little is known about the competing risk of bleeding from clopidogrel in "real world" clinical practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research